| Literature DB >> 25580906 |
Maria V Papadopoulou1, William D Bloomer, Galina I Lepesheva, Howard S Rosenzweig, Marcel Kaiser, Benjamín Aguilera-Venegas, Shane R Wilkinson, Eric Chatelain, Jean-Robert Ioset.
Abstract
3-Nitro-1H-1,2,4-triazole-based amides with a linear, rigid core and 3-nitrotriazole-based fluconazole analogues were synthesized as dual functioning antitrypanosomal agents. Such compounds are excellent substrates for type I nitroreductase (NTR) located in the mitochondrion of trypanosomatids and, at the same time, act as inhibitors of the sterol 14α-demethylase (T. cruzi CYP51) enzyme. Because combination treatments against parasites are often superior to monotherapy, we believe that this emerging class of bifunctional compounds may introduce a new generation of antitrypanosomal drugs. In the present work, the synthesis and in vitro and in vivo evaluation of such compounds is discussed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25580906 PMCID: PMC4337820 DOI: 10.1021/jm5015742
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446